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The Streptococcus bovis/Streptococcus equinus complex (SBSEC) comprises several
species inhabiting the animal and human gastrointestinal tract (GIT). They match the
pathobiont description, are potential zoonotic agents and technological organisms in
fermented foods. SBSEC members are associated with multiple diseases in humans
and animals including ruminal acidosis, infective endocarditis (IE) and colorectal cancer
(CRC). Therefore, this review aims to re-evaluate adhesion and colonization abilities
of SBSEC members of animal, human and food origin paired with genomic and
functional host-microbe interaction data on their road from colonization to infection.
SBSEC seem to be a marginal population during GIT symbiosis that can proliferate
as opportunistic pathogens. Risk factors for human colonization are considered
living in rural areas and animal-feces contact. Niche adaptation plays a pivotal role
where Streptococcus gallolyticus subsp. gallolyticus (SGG) retained the ability to
proliferate in various environments. Other SBSEC members have undergone genome
reduction and niche-specific gene gain to yield important commensal, pathobiont and
technological species. Selective colonization of CRC tissue is suggested for SGG,
possibly related to increased adhesion to cancerous cell types featuring enhanced
collagen IV accessibility. SGG can colonize, proliferate and may shape the tumor
microenvironment to their benefit by tumor promotion upon initial neoplasia development.
Bacteria cell surface structures including lipotheichoic acids, capsular polysaccharides
and pilus loci (pil1, pil2, and pil3) govern adhesion. Only human blood-derived SGG
contain complete pilus loci and other disease-associated surface proteins. Rumen
or feces-derived SGG and other SBSEC members lack or harbor mutated pili. Pili
also contribute to binding to fibrinogen upon invasion and translocation of cells
from the GIT into the blood system, subsequent immune evasion, human contact
system activation and collagen-I-binding on damaged heart valves. Only SGG carrying
complete pilus loci seem to have highest IE potential in humans with significant
links between SGG bacteremia/IE and underlying diseases including CRC. Other
SBSEC host-microbe combinations might rely on currently unknown mechanisms.
Jans and Boleij Road to Infection: Streptococcus bovis in Host-Microbe Interactions
Comparative genome data of blood, commensal and food isolates are limited but
required to elucidate the role of pili and other virulence factors, understand pathogenicity
mechanisms, host specificity and estimate health risks for animals, humans and food
alike.
Keywords: Streptococcus gallolyticus, Streptococcus lutetiensis, Streptococcus infantarius, virulence, infective
endocarditis, colorectal cancer, pilus, microbiota
GENERAL INTRODUCTION TO THE
RELEVANCE OF THE STREPTOCOCCUS
BOVIS/STREPTOCOCCUS EQUINUS
COMPLEX
Streptococcus bovis/Streptococcus equinus complex (SBSEC)
bacteria are Gram-positive species that inhabit the
gastrointestinal tract (GIT) of animals and humans. Most
SBSEC have been described as commensal bacteria, but some
cause serious infections such as bacteremia and infective
endocarditis (IE) in humans and animals and match the
pathobiont description (Chow et al., 2011; Boleij and Tjalsma,
2013; Jans et al., 2015, 2016). They are associated with underlying
conditions including occult colorectal cancer (CRC) (Boleij et al.,
2011c), which highlights the importance of SBSEC members in
public- and animal health alike.
Furthermore, SBSEC members are detected in food products
including fermented milk in sub-Saharan Africa, Asia and
Southern Europe, fermented fish in Asia and fermented plants
in sub-Saharan Africa and Latin America suggesting a range
of habitats and adaptability to different environments for
these bacteria (Jans et al., 2015, 2017). Recent advances in
phenotypic and molecular technologies provide more detailed
classification abilities at various levels from species to sequence
type. This advanced classification scheme helps to elucidate the
SBSEC population structure, disease associations, transmission
routes and host specificity (Dumke et al., 2014; Shibata
et al., 2014; Jans et al., 2016). It is still unclear how SBSEC
members establish from commensal organisms to pathogens,
particularly relating to survival, colonization, adhesion, invasion
and interaction with the host immune system. Furthermore,
the causality of SBSEC in CRC is not yet proven which leaves
the bacterial-driver-passenger model as important theory to
describe the potential mechanisms of host-microbe interaction
(Tjalsma et al., 2012).
Therefore, this narrative review aims to provide a
comprehensive overview for the following questions in
relation to SBSEC members on their road to infection regarding
prevalence, transmission, niche colonization and mechanisms
for adhesion, invasion and infection establishment within the
human-animal-food system (Figure 1):
(1) What abilities help SBSEC members to colonize different
body sites or ecological niches and facilitate transmission?
(2) Which factors determine SBSEC to evolve from commensal
to pathogen?
(3) What is the prevalence of SBSEC members in different
habitats in relation to clinical manifestations and infections?
(4) Which genetic factors are known to encode for these abilities
and can be linked to experimental studies?
BASIC TAXONOMY AND IDENTIFICATION
OF THE SBSEC
SBSEC members are group D streptococci, although the
Lancefield group D antiserum reaction is not ubiquitous (Beck
et al., 2008). The SBSEC is comprised of several different
species, which in this review will be used according to following
nomenclature: Streptococcus equinus (SE), Streptococcus
infantarius subsp. infantarius (SII), Streptococcus lutetiensis
(SL), Streptococcus alactolyticus and three subspecies of the
clade Streptococcus gallolyticus, namely gallolyticus (SGG),
macedonicus (SGM) and pasteurianus (SGP). The taxonomic
assignment of SL as separate species is not fully agreed upon
and also referred to as Streptococcus infantarius subsp. coli
(Dekker and Lau, 2016). When no distinction was made between
subspecies, the old nomenclature Streptococcus bovis (SB) was
used (Schlegel et al., 2000, 2003; Poyart et al., 2002; Jans et al.,
2015). Biotype differentiation is based on the ability to produce
acid from mannitol (biotype I = SGG) or not (biotype II = SE,
SGP, SL, and SII) (Schlegel et al., 2003; Jans et al., 2015). For full
phenotype descriptions, we refer to Bergey’s Manual and their
implementations in API and VITEK identification approaches
(Whiley and Hardie, 2009).
Alternative identification approaches utilize Matrix Assisted
Laser Desorption/Ionization Time Of Flight Mass Spectrometry
(MALDI-TOF MS) to identify and discriminate species of the
SBSEC but results in unreliable identification of SGM and a
roughly 80% identification rate for SGG, SGP and SL (Hinse
et al., 2011a; Ben-Chetrit et al., 2017). Furthermore, DNA-based
approaches are widely applied using single gene PCR and qPCR
assays on 16S rRNA gene (Jans et al., 2012b), sodA (Poyart et al.,
1998), groES/groEL (Chen et al., 2008; Lazarovitch et al., 2013;
Sheng et al., 2014), recN and gyrB (Lopes et al., 2014) as well as
multi locus sequence typing (Dumke et al., 2014; Shibata et al.,
2014; Jans et al., 2016).
PREVALENCE AND COLONIZATION OF
SBSEC IN ANIMALS AND HUMANS
Prevalence and Colonization in Animals
SBSEC are mainly described as colonizers of the rumen, crop and
cloaca of animals and colon of humans. SBSEC members have
been isolated from the GIT or blood system of birds, companion
animals, livestock (ruminants, poultry and pigs), marsupials,
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FIGURE 1 | SBSEC - the road to infection. Graphical overview of the different niches inhabited by SBSEC members as well as relevant aspects of host colonization,
adherence, invasion and infection covered in the corresponding chapters indicated by bullet point numbers. 1. Prevalence and colonization of SBSEC in animals and
humans, 2. Transmission and niche adaptation of SBSEC members, 3. Mechanisms and virulence factors responsible for adhesion and host colonization by SBSEC
members, 4. Invasion and infection establishment, 5. Clinical infections and host-immune response due to SBSEC in animals and humans.
aquatic mammals and game (Jans et al., 2015), but prevalence
data is limited to birds, cattle and lamb. SGG was found in over
90% of fecal droppings in turkey flocks and reached up to 80%
prevalence in pigeon crop and cloaca samples (De Herdt et al.,
1994a,b; Schulz et al., 2015). SBSEC members were also isolated
from chicken crops, but less frequently and not as predominant
bacteria (Baele et al., 2001).
In ruminants, SBSEC members are considered as aerotolerant
components of the rumen epithelial surface (epimural)
microbiota (Mead and Jones, 1981). SBSEC members are
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estimated to contribute 106 to 107 cells per milliliter of rumen
content (Hudson et al., 2000). Their prevalence in cattle is
estimated between 20 and 90% with lowest prevalence at early
ages (Jans et al., 2015) while in lambs an early live predominance
of SBSEC is suggested (Mueller et al., 1984). Colonization and
predominance is likely affected by feed composition as shown for
reindeers where high SBSEC colonization correlates with higher
quantities of starch-rich feed during the summer months (Orpin
et al., 1985). SBSEC members are also supplied directly to young
calves and goats as probiotics to support the establishment of
an anaerobic rumen microbiota and to benefit from consistent
α-amylase activity for feed digestion (Kmet et al., 1993; Kumar
et al., 2016). SBSEC members therefore seem to form an integral
part of the GIT microbiota of birds whereas ruminants feature
age-dependent and possible host-associated SBSEC prevalence.
Prevalence in Healthy Humans
The fecal carriage rate of SBSEC member in humans is varying
from five to over 60% (Table 1) (Klein et al., 1977; Noble, 1978;
Potter et al., 1998; Abdulamir et al., 2010; Al-Jashamy et al., 2010;
Chirouze et al., 2013; Lopes et al., 2014; Boltin et al., 2015; Dumke
et al., 2017; Kaindi et al., 2017). This variation might depend
on detection techniques and regional differences. Furthermore,
most studies were conducted using a hospital-derived population
with possible differences in age, sex and underlying diseases that
limits extrapolation to the general population. (Huang et al.,
2008; Chirouze et al., 2013; Lopes et al., 2014; Dumke et al., 2017;
Harris et al., 2017).Oral niche colonization in humans seems to
be infrequent, but isolation of SII, SGP, and SE was confirmed
from dental plaques and root caries lesions (Sissons et al., 1988;
Shen et al., 2005; Arul and Palanivelu, 2014).
Selective Colonization of CRC Patients and
Preliminary Causal Evidence
Selective Colonization of CRC Patients
Fecal carriage of SBSEC members associated with CRC was
initially reported to be 56% in 63 CRC patients compared
to 11% in 105 healthy controls (Table 1) (Klein et al., 1977).
This association has since been reported in a range of 6–
46% in patients with adenomas and CRC vs. 7–14% in control
patients (Abdulamir et al., 2010; Al-Jashamy et al., 2010; Chirouze
et al., 2013; Boltin et al., 2015; Kaindi et al., 2017). Of these
five studies, only two observed a significant carriage difference
between healthy and neoplasia patients but one suggested a novel
association of SII prevalence with hemorrhoids (Al-Jashamy
et al., 2010; Kaindi et al., 2017).
The selective association with CRC tissue is also controversial.
While no specific association of SBSEC members with CRC
tissue was observed on small sample sets based on phenotypic
identification (Norfleet and Mitchell, 1993; Potter et al., 1998),
more recent DNA-based approaches approve of such an
association ranging from 0 to 2% in controls, 47% in normal
tissue of cancer patients and 3–74% in tumor tissues (Table 1)
(Abdulamir et al., 2010; Andres-Franch et al., 2017; Kumar et al.,
2017). Interestingly, tumor tissue of patients with bacteremia was
more often positive for SGG (48.7%) than that of patients without
bacteremia (32.7%) based on sodA gene PCR, which increased
the detection rate of SGG from 27% and 16%, respectively,
based on selective culturing. (Abdulamir et al., 2010). Tumor
tissues harboring SGG were also significantly associated with
co-infection by Epstein-Barr virus (OR: 9.49; 95% CI: 1.1–82.9)
(Andres-Franch et al., 2017). Nevertheless, two other studies
using a culture-based and qPCR-based approach still suggested
no association between tumorous (0–15%) and non-tumorous
tissues (0–12%) for SB/SGG (Boltin et al., 2015; Viljoen et al.,
2015).
These contradicting data on SBSEC tumor tissue colonization
might relate to patients with clinical infections of SBSEC
(Abdulamir et al., 2010) or without any clinical symptoms
(Viljoen et al., 2015; Andres-Franch et al., 2017), differences
in detection techniques (culture-independent vs. selective
culturing) or study population. This also indicates a non-
obligatory relationship of SGG or SBSECwith CRC. SBSECmight
only proliferate if certain requirements to facilitate colonization
are met to become passengers as hypothesized in the bacterial-
driver-passenger model (Tjalsma et al., 2012).
Preliminary Causality of SBSEC in CRC
Only minimal evidence for a causal relationship between SBSEC
and CRC exists. Wall-extracted antigens from SGG NCTC8133,
a human fecal isolate with controversial earlier classification as
SII or SE, and its active S300 fraction are suggested to induce
cell proliferation, polyamines and aberrant crypt foci in the distal
colon of azoxymethane-treated rats (Ellmerich et al., 2000b; Biarc
et al., 2004; Jans et al., 2016). In human CRC cell lines, stationary
SGG strains TX20005 and TX20030 increased cell proliferation
of HCT116, HT-29 and LoVo but not of SW480, SW1116, human
lung carcinoma cell line A549, kidney epithelial cell line HEK293,
human normal colon epithelial cell lines CCD841, CoN, and
FHC suggesting the need for specific conditions to facilitate cell
proliferation (Kumar et al., 2017).
The adenomatous polyposis coli tumorsuppressor gene APC
is inactivated in many CRCs. This leads to an accumulation
of β-catenin in the nucleus (He et al., 1998) thereby activating
the c-Myc oncogene. Increased levels of β-catenin and c-Myc
were detected in CRC cells after SGG incubation. This effect
was not observed for SII, SGP, and SGM or for live SGG
separated by trans-well membranes from cells, nor with bacterial
supernatants, heat-killed bacteria or bacterial lysates suggesting a
necessity of live SGG and direct SGG-cell contact (Kumar et al.,
2017).
In azoxymethane-treated mice, inoculation with SGG led to
increased cell proliferation, β-catenin accumulation in colonic
crypts and higher numbers of tumors and dysplasia grade
supporting a potential tumor-promoting role for SGG (Kumar
et al., 2017). This effect was only observed for SGG strains
able to induce cell proliferation in vitro (Kumar et al., 2018).
The increase in cell proliferation was correlated with increased
adhesion abilities in vitro. In vivo such strains also had an
increased ability to colonize the mucosa in both C57BL6 as A/J
mice. Therefore, the original bacterial driver-passenger model
(Tjalsma et al., 2012) might need to be updated regarding the
potential driving role of SGG. If SGG contributes to tumor
development it would exert its effects probably after colonization
of neoplastic sites as a passenger, which might depend on the
specific strain and contribute to tumor progression rather than
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tumor initiation (Boleij and Tjalsma, 2013). In fact, the presence
of polyps in the intestinal tract of Notch/APC mice allowed
colonization and persistence of SGG UCN34 colonization, which
was 1,000-fold higher than Notch control mice (Aymeric et al.,
2018). However, no preferential adherence to tumor tissue sites
was observed. Colonization was evenly distributed through the
ileum and proximal colon, stimulated by secondary bile acids and
was dependent on bacteriocins BlpA and BlpB that compete with
other enterococci in the gut (Aymeric et al., 2018).
Interestingly, in vitro cultivation experiments suggested
a growth advantage for SGG and SGM in the tumor
microenvironment. Cultivation of SGG UCN34 and SGM
CIP105683T in spent medium from CRC cells HT-29, SW480,
HCT116, and Caco-2 was used to simulate utilization of
metabolites from the tumor microenvironment (Boleij et al.,
2012a). SGG and SGM displayed significantly increased growth
rates in spent medium of Caco-2 cells whereas the growth rates
of e.g., Salmonella enterica subsp. enterica serovar Typhimurium,
Staphylococcus lugdunensis or Enterobacter cloacae were reduced,
suggesting a significant advantage for SBSEC to proliferate
in the spent CRC metabolites. The major changes in protein
expression patterns were related to an upregulation of pyrimidine
biosynthesis and glycolysis, particularly glycerolypid, glycosis
and fructose utilization; and a downregulation of purine
metabolism. Furthermore, SGG seems to be specifically capable
to use secondary glucose metabolites fructose 6-phosphate
and 3-phosphate glyceric acid (Boleij et al., 2012a). As the
tumor microenvironment features increased levels of lactate,
glucose derivatives, amino acids, lipids and fatty acids, SGG
likely has an advantage to proliferate in this niche (Boleij et al.,
2012a).Therefore, SGG can be described as an opportunistic
pathobiont benefiting from the favorable oncogenic environment
to colonize the host. This eventually promotes its translocation
and systemic dissemination, in select cases leading to clinical
infections.
TRANSMISSION AND NICHE ADAPTION
OF SBSEC MEMBERS
Transmission of SBSEC Between Hosts
The prevalence in the GIT of animals and humans facilitates
transmission between animals and humans via feces and saliva
(Dumke et al., 2015, 2017). Over a duration of 4 weeks, SB
counts of an estimated 107 CFU/g broiler feed and 108 CFU/g
wheat straw were only reduced by one log unit indicating high
transmission possibility (Guy et al., 1980; Mackey and Hinton,
1990). Furthermore, soil clay adhesion of SB from bovine feces
is very strong and cannot be desorbed after 24 h whereas long-
term persistence seems weak but possibly sufficient to establish
transmission within shorter time frames as observed among
poultry flocks, surrounding environment and workers. In laying
hens, colonization of non-carrier birds introduced into an SGG-
positive flock took approximately 35 weeks and occurred likely
via feed and feces (Guy et al., 1980; Dumke et al., 2015; Schulz
et al., 2015). SGG isolates of identical sequence types where
thereby causing infection in one worker and contributing to in-
flock and old-young transmission in hens (Dumke et al., 2015).
Similarly, sequence types were shared between turkey, pigeons,
chicken and humans (Schulz et al., 2015). Rural residency, close
animal-human contact and the use of manure as fertilizer were
identified as risk factors for colonization with SGG, SGP, SII, SL,
and SB in humans (Giannitsioti et al., 2007; Corredoira et al.,
2008; Dumke et al., 2017).
Transmission via the fecal-oral or food-oral route requires
survival of the gastric passage for colonization of the gut. Survival
to simulated gastric conditions is dependent on the SB strain,
gastric pH and feed ingestion. At pH < 2.5, survival is minimal
whereas at pH 3.0 a reduction of approximately 3 log units was
observed for SII while SGM did not survive, suggesting species-
specific abilities to survive and reach the intestine in sufficient
numbers for colonization (Ripamonti et al., 2011; Jans et al.,
2016). The role of transmission via fermented food products
that contain SII, SL, or SGM particularly in sub-Saharan Africa,
Southern Europe, Asia and Latin America is not yet clear and
niche adaptation might play a pivotal role in their ability to
colonize the host (Jans et al., 2015, 2017; Kaindi et al., 2017).
Niche Adaptation of SBSEC Members
SBSEC members adapt to multiple niches. In the rumen,
the main carbon sources are largely available in the form of
plant fibers. Their utilization is a key feature of many SBSEC
members. Proteolysis and peptidase activity are important for the
breakdown of proteins to ammonia (Wallace and McKain, 1991)
that further supports growth of SBSEC members (Sales-Duval
et al., 2002). α- galactosidase, β-glucanases, and endoglucanases
of SBSEC play important roles for the degradation of complex
carbohydrates in ruminants and chicken (Bailey, 1963; Ekinci
et al., 1997; Beckmann et al., 2006). Most of these enzymes are
adapted to GIT conditions with a narrow pH optimumof pH 5.6–
6.3 and a temperature optimum of 37–42◦C (Bailey, 1963; Wang
et al., 2015; Chen et al., 2016), except for α-amylase and lactate
dehydrogenase activity that increases at pH 5.5 vs. pH 6.5 and
is possibly part of a self-feeding loop for lactate overproduction
(Chen et al., 2016). At pH > 6.0, metabolism is directed toward
production of formate, acetate and ethanol (Chen et al., 2016),
while below pH 5.5, it is directed toward lactate, particularly
in the event of excess glucose sources such as starch (Gunsalus
and Niven, 1942; Russell and Hino, 1985; Asanuma and Hino,
1997). Ruminal acidosis results in a drop below pH 5.5 causing
bloat in the rumen (Penner et al., 2007). Despite inconclusive
causality, evidence suggests initiation by the overgrowth of SB
in combination with Prevotella, Ruminococcus, Streptococcus,
and Lactobacillus and the parallel inability of lactate utilizers
such as Megasphaera elsdenii and Selenomonas ruminantium to
metabolize lactate (Palmonari et al., 2010; Wang et al., 2015;
McCann et al., 2016).
Particularly SGG has retained the ability to utilize a wide
range of carbon sources typical for the rumen. This feature is
minimized in SGM and SII or modified to a different variety of
carbon sources in SGP (Rusniok et al., 2010; Lin et al., 2011b;
Papadimitriou et al., 2014). SGP ATCC43144 in contrast to SGG
ATCC43143 harbors a α-L-rhamnosidase, several endo-β-N-
acetylglucosaminidase, glucokinase, glucosidases, mannosidases
to utilize specific carbon sources available in the gut originating
from plant cell walls, biofilms, glycosides, and glycolipids (Lin
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et al., 2011b). SGG is the only Streptococcus known so far to
use malate via the malolactic enzyme (Gallo_2048) and a malate
transporter (Gallo_2049) as well as degrade tannins encoded by
tanA, that are otherwise toxic to many bacteria (Rusniok et al.,
2010; Papadimitriou et al., 2014). SGG UCN34 is also able to
hydrolyze bile salts, an important feature to survive in the small
intestine. SGG is prototroph for all 20 amino acids. Besides, SGG
harbors partial biosynthesis pathways for biotin and thiamine
to support growth in varying conditions including the rumen,
intestine and also the blood system (Rusniok et al., 2010).
Niche adaptation is also observed in SII, SGM, and SGP
via gene loss and gain. They cannot biosynthesize pantothenate
and biotin (Lin et al., 2011b; Papadimitriou et al., 2014) but
depend on them for growth (Barnes et al., 1961). Dairy variants
of SII strains adapted to the dairy environment via a modified
lactose (LacS and LacZ instead of phosphotransferase) and
peptide metabolism (duplication of oligopeptide transporters)
(Jans et al., 2012a, 2013). Dairy SGM lost or harbor truncated
genes for degradation of plant carbohydrates and detoxification
of substances relevant for survival in the rumen that are likely
obsolete in the dairy niche. In addition, dairy SGM gained gene
clusters for casein hydrolysis, lactose and galactose metabolism
for optimal utilization of these milk components (Papadimitriou
et al., 2014). Both dairy SII and SGM possess lactocepin with high
sequence similarity to PrtS CEP of S. thermophilus responsible for
milk protein degradation. Furthermore, SGP showed gene loss
likely related to adaptation to nutrient-rich environments and an
overall genome reduction compared to SGG (Papadimitriou et al.,
2014). These findings demonstrate the high adaptability of SBSEC
members to different carbon and protein sources not only within
the GIT, but also within the dairy environment.
Niche adaptability is also reflected by a high genome plasticity
among SBSEC members. The pangenome is increasing at a
high rate entailing numerous unique genes for each new
strain added (Hinse et al., 2011b). Nearly all SBSEC genomes
reveal horizontal gene transfer relating to general carbohydrate
metabolism, capsular polysaccharides, antimicrobial resistance
or tannase as the key discriminator of SGG (Rusniok et al.,
2010; Hinse et al., 2011b; Lin et al., 2011b; Jans et al., 2013;
Papadimitriou et al., 2014; Kambarev and Caté, 2015; Grimm
et al., 2017a; Kambarev et al., 2017). Natural competence operons
and pseudopilus identified in SII and SGG likely contribute to the
success of horizontal gene transfer and thus to niche adaptation
(Rusniok et al., 2010; Lin et al., 2011b; Morrison et al., 2013; Jans
et al., 2016). As a consequence, SBSEC members feature highly
diverse metabolic abilities and likely also different virulence
factors depending on the species and different impact depending
on the niche colonized.
MECHANISMS AND VIRULENCE FACTORS
RESPONSIBLE FOR ADHESION AND HOST
COLONIZATION BY SBSEC MEMBERS
The establishment of bacteria in a niche depends on a
multitude of factors relating to adherence, signaling, nutritional
adaptation and host modulation. Some of the key factors
involved in adhesion and colonization in streptococci include
cell-wall anchored factors such as LPXTG-motif proteins,
anchorless factors including the cell capsule, two-component
signal transduction systems for signaling or released/secreted
factors such as exopolysaccharides to form biofilms (Nobbs et al.,
2009; Brouwer et al., 2016).
Employing epithelial and endothelial cell lines provides an
advanced model to study adhesion via bacteria-cell interactions.
Adhesion capabilities can vary depending on the environment
and the associated microbiota as well as the cell type present.
Given the presence of SBSEC members in GIT and the blood
system, adhesion and colonization have to be comprehensively
assessed using designated cell lines. This includes cells originating
from oral (primary buccal epithelial cells), gastric (rumen
epithelial cell line), intestinal (human CRC cell lines Caco-2,
HT-29, HCT116 and mucus-producing HT-29 MTX; mouse
rectum carcinoma CMT-93) and venous sites (human vascular
endothelial EA.hy926, human umbilical vein HUVEC, unnamed
saphenous vein and mouse endothelial tumor EOMA).
Adhesion to Epithelial Cell Lines of the GIT
Oral epithelial cells represent the first cells in the GIT to interact
with SBSEC members upon ingestion. Adhesion to buccal
epithelial cells of human IE-derived SB biotype I and II strains
was around 2–3 times higher than that of commensal reference
strain SB DSM20480T = NCTC8177 (Von Hunolstein et al.,
1993), suggesting that epithelial adhesion is particularly present
among IE-derived strains and likely dose-dependent (Ellmerich
et al., 2000a).
Adhesion in the rumen seems to be pH and cell type
dependent. Highest adhesion of SB strains to rumen epithelial
cells was observed between pH 7.0–7.3. Near ruminal pH
of 6.5, adhesion was still elevated suggesting that these SB
strains adapted to the rumen (Styriak et al., 1994; Wang et al.,
2015). An important factor for adhesion in the rumen was
related to epithelial keratinization and particularly glycocalix
(a glycoprotein and glycolipid cell surface layer) present
on differentiated cells (Table 2). Keratinization significantly
enhanced adherence of SB and enabled adhesion for those isolates
unable to adhere to non-keratinized cells (Semjén andGálfi, 1990;
Styriak et al., 1991, 1992). However, host-specificity of SB strains
using sheep and calve rumen epithelial cells was inconclusive.
Therefore, it remains unclear whether host-specificity is a driving
factor in rumen colonization (Semjén and Gálfi, 1990; Styriak
et al., 1992).
In the colon, adhesion of SBSEC members was assessed using
epithelial CRC cell lines CMT-93, Caco-2 and HT-29 (Table 2).
Adhesion to these CRC cell lines was observed for several SBSEC
species including SL, SGG and SGM. Animal-derived SL strains
(sea otter IE, feces, brain and lymph node isolates) adhered highly
variable to CMT-93 andCaco-2. Significant adhesion (>0.2–0.3%
of the inoculum) to CMT-93 and Caco-2 was rare within this
strain pool and at slightly lower levels than the S. Typhimurium
reference strain (Counihan et al., 2015). Adhesion to CMT-93
was generally lower than and without correlation to that of Caco-
2 even for S. Typhimurium (Counihan et al., 2015) suggesting
low suitability of CMT-93 cells for SBSEC adhesion assessment
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and possibly the need to evaluate sea otter-derived SL for host
specificity.
Adhesion abilities toward Caco-2 and HT-29 of human-
derived SGG and dairy SGM was low (<15% of inoculum)
to intermediate (20–50% of inoculum) for SGG and SGM/SE,
respectively (Table 2). Low adhesion was comparable with that of
S. Typhimurium whereas intermediate adhesion was comparable
to that of E. coli and Lb. plantarum reference strains, but
significantly lower than the 80–98% observed for E. faecalis.
Differences were particularly evident for SGG NCTC8133 that
more efficiently adhered to Caco-2 than HT-29 (Boleij et al.,
2011b). A comparative assessment of blood-derived SGG of
IE patients indicated significantly enhanced adhesion abilities
to HT-29 cells, particularly among strains able to promote
tumor cell proliferation (Kumar et al., 2018). This differentiation
between proliferation-promoting and non-promoting SGG was
paralleled by the ability to colonize mice. Interestingly, mice
colonization was increased in A/J type mice compared to
C57BL/6 mice, which might be related to different host factors
required for colonization (Kumar et al., 2018). Therefore, certain
tumor-promoting strains might possess enhanced adhesion
capabilities and thus a selective advantage particularly in a tumor
environment presenting favorable factors. General adhesion of
SBSEC members to CRC cell lines however seems limited in
comparison to other gut pathogens.
Adhesion to Endothelial Cell Lines
Similar to epithelial cell lines, dose-dependent adhesion behavior
was also observed for SGG NCTC8133 (human fecal isolate) and
SGP ATCC43144 (human blood isolate) to human saphenous
vein endothelial cell lines (Table 2). Especially at low inoculums,
binding to endothelial cells was higher than to epithelial cells
suggesting a preference toward endothelium (Ellmerich et al.,
2000a). This was also observed among primarily human IE SGG
isolates adhering to EA.hy926 cells but not with animal feces-
derived SGG DSM16831T (Vollmer et al., 2010). Mechanical
stress on HUVEC cells had no influence on adherence suggesting
that SGG actively colonizes endothelial tissues (Vollmer et al.,
2010). Interestingly, only blood isolates of SGG express the blood-
group antigen sialyl lewis-X (sLex) on their cell surface. sLex is
normally expressed on the cell surface of leukocytes enabling
rolling of leukocytes on the endothelium. This might increase
SGG adhesion to endothelial cells (Hirota et al., 1996).
Significant adhesion to endothelial HUVEC-C cells was
observed in multiple IE and septicemia SL strains isolated from
sea otters (Counihan et al., 2015). The ability to adhere to
cell lines other than HUVEC-C was minimal; only one strain
showed adhesion to human epithelial Caco-2, human endothelial
HUVEC-C and mouse endothelial tumor EOMA cells (Table 2).
The other strains showed minimal adhesion to mouse/human
epithelial or endothelial cells, suggesting key differences in
adhesion mechanisms to different cell types and possibly host
origin. In general, isolates from heart or blood adhered better
to intact endothelial cells and support possible IE establishment
without previous history of heart disease (Counihan et al., 2015).
However, general adhesion of SL strains was in the range of
0.05–0.2% of the inoculum and thus significantly lower than the
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2% of human clinical Staphylococcus aureus ATCC25923 used
as reference (Counihan et al., 2015). The biological impact to
trigger IE despite this significantly lower adhesion ability of SL
in contrast to S. aureus will require further evaluation in relation
to host specificity and mechanisms responsible for endothelial
tissue colonization by SBSEC members in vitro and in vivo.
Binding to Extracellular Matrix Proteins
Extracellular matrix proteins (ECM) are an important
component to facilitate bacterial binding to epithelial and
endothelial cell surfaces and thus niche colonization in humans
and animals. Collagen thereby plays an important role. Collagen
type I is present in organ capsules and scar tissue, such as on
damaged heart valves. Collagen type IV is the main constituent
of basement membranes and can become exposed at tumor sites
(Tanjore and Kalluri, 2006; Boleij and Tjalsma, 2013).
Adhesion to collagen type I and IV is a key feature of
SGG (Table 3). Most SGG strains derived from human blood
cultures of IE or bacteremia patients, pigeons suffering from
streptococcosis (SGG and SGP) and SL strains derived from sea
otters with IE, but also fecal and dairy SBSEC isolates displayed
binding to collagen type IV. In contrast, binding to collagen type
I was a feature mostly associated with human blood-derived SGG,
SGP, SII and SL isolates and partially also with SGM isolates
(Vanrobaeys et al., 2000a; Sillanpää et al., 2008; Vollmer et al.,
2010; Boleij et al., 2011b; Counihan et al., 2015; Grimm et al.,
2018). Among a panel of human and food-derived SII and SL
as well as dairy SGM, adhesion to collagen type I and IV was
particularly present in human blood isolates (Boleij et al., 2011b;
Jans et al., 2016). In contrast, SGG considered as commensals
and isolated from human feces, pigeons and ruminants including
the SGG type strain rarely bound to collagen type I, III and
IV (Table 3). Similar differences were also observed between
SGG from infected vs. SGG from healthy humans featuring
high vs. low adhesion, respectively (Grimm et al., 2018). SGG
NCTC8133 and SGP strain ATCC43144 were only shown to bind
collagen type IV whereas SGP DSM15351T strains displayed no
adhesion to collagen type I and IV. Other collagen types bound by
human IE-derived SGG are collagen type II (96%) and to a lesser
extent collagen type V (40%) (Table 3) (Ellmerich et al., 2000a;
Sillanpää et al., 2008; Vollmer et al., 2010). Differences in collagen
adhesion patterns therefore seem to exist between animal and
human-derived strains even within the same species. Whether
these different adhesion patterns among SGG and other SBSEC
members also translate into different abilities to cause disease
remains to be investigated.
Connective tissue and the tumor-microenvironment contain
an extensive network of ECM including collagen, laminins,
fibronectin, proteoglycans, and hyaluronans (Peddareddigari
et al., 2010). SL strains from sea otters adhered to fibronectin,
laminin, and hyaluronic acid in all cases (Table 3) (Counihan
et al., 2015). Also human blood-derived SII and SL featured high
adhesion abilities to fibronectin (Jans et al., 2016). Interestingly,
the SL genome features relevant hits to adhesion factors such as
pneumococcal cell surface adherence protein A PavA involved
in fibronectin-binding and the laminin-binding protein Lmb
(Jin et al., 2013). Binding to fibronectin is also observed in the
SGG type strain and the majority of pigeon-derived SGG strains
(Table 3). Interestingly, fibronectin-binding is less prevalent
in human-derived SGG and SGP with the exception of SGG
NCTC8133 and human blood strain SGP ATCC43144 (Ellmerich
et al., 2000a; Vanrobaeys et al., 2000a; Sillanpää et al., 2008;
Vollmer et al., 2010; Jans et al., 2016). Furthermore, rumen-
derived SB strains showed low or no binding to both human
and porcine fibronectin (Styriak et al., 1999). Similar, the SII type
strain, SII dairy and SL human commensal strains showed with
a few exceptions only minor adhesion abilities to fibronectin,
collagen type I and IV, mucin and fibrinogen (Table 3) (Jans et al.,
2016).
Fibrinogen-binding is in contrast to fibronectin-binding a
common feature also among human IE SGG strains, dairy
SGM, human SII and SL blood isolates (Table 3) (Ellmerich
et al., 2000a; Sillanpää et al., 2008; Vollmer et al., 2010; Jans
et al., 2016). Human IE-derived SGG also showed interactions
with tenascin, laminin and vitronectin (Ellmerich et al., 2000a;
Sillanpää et al., 2008; Vollmer et al., 2010). In contrast, rumen
SB strains showed mostly moderate or weak adhesion to bovine
lactoferrin, vitronectin, heparin, and BSA. None of the SB
strains bound to human serum albumin (Table 3) (Styriak et al.,
1999). These differences in ECM adhesion patterns between
animal and human strains might therefore be important for
their colonization abilities of different body sites. These patterns
furthermore suggest different adhesion mechanisms in SL, SGG
and other SBSEC members (Lin et al., 2011b; Papadimitriou
et al., 2014). Particularly human and animal blood isolates seem
to have the ability to bind fibrinogen, while fibronectin-binding
is variable, which implies different adhesion abilities regarding
fibronectin in the tumor-microenvironment and fibrinogen at
damaged sites requiring blood clotting.
Biofilm Formation, Exopolysaccharides,
Dextran Production and Capsular
Polysaccharides
Adhesion and biofilm-forming abilities are linked to colonization
and persistence in the GIT. SB produce at least two types
of polysaccharides: (1) water-soluble glucans, often dextrans,
comprised of α-1:6 linked glucose units (Bailey, 1959); and (2)
capsular polysaccharide (Bailey and Oxford, 1958). GtfA in SGG
was found to produce water-insoluble α-1,3-linked glucosidic
polymers whereas GtfB encoded for α-1,3-linked water-insoluble
and α-1,6-linked glucosidic water-soluble polymers (Lin et al.,
2011b). Both types of polysaccharides have specific roles in
adhesion, colonization and host immune evasion (Nobbs et al.,
2009; Isenring et al., 2018). The ability to form biofilms is
however not directly correlated to virulence and needs to be
carefully distinguished (Vollmer et al., 2010).
Biofilm formation was observed with SBSEC strains from
GIT, blood and food origin (Vollmer et al., 2010; Boleij et al.,
2011b; Jans et al., 2016). SII and other SBSEC members were
also observed to form biofilms on human teeth featuring various
degrees of auto- and co-aggregation with other oral microbes
(Shen et al., 2005; Arul and Palanivelu, 2014). Even outside a host,
biofilm formation to uncoated plastic and stainless steel surfaces
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was observed for all SBSEC species of blood, animal and dairy
origin (Flint et al., 1997, 1999; Jans et al., 2016).
Polysaccharides are major constituents of biofilms
(Christensen, 1989; Nobbs et al., 2009). SGG, SL and many
SBSEC members are known to produce extracellular glucan
encoded by glycosyl-transferases similar to GtfA, GtfB, and
GtfC of S. mutans but lacking in SGP ATCC43144 (Rusniok
et al., 2010; Lin et al., 2011b). Instead, SGP harbored a strain-
specific exopolysaccharide biosynthesis gene cluster featuring
sequence identity highest with those of Bacillus cereus and
Clostridium thermocellum (Lin et al., 2011b). Generally, this
suggests that from a common SBSEC ancestor, SGG likely kept
most biofilm-related loci while the respective loci were either
absent or comprised of pseudogenes in SGP, SII and SGM
potentially reducing or abrogating biofilm formation capabilities
in comparison to SGG (De Vuyst and Tsakalidou, 2008; Lin
et al., 2011b; Papadimitriou et al., 2014). Biofilm production
might therefore be SBSEC-species dependent but older data are
inconclusive in this respect.
Dextran production from rumen SB biotype II isolates of
sheep, calve and cow is particularly dependent on available
sugar compounds and a CO2 source. In contrast to capsular
polysaccharides, the production of dextran is limited and directly
correlated with the available sucrose concentration (Bailey and
Oxford, 1958; Barnes et al., 1961; Cheng et al., 1976). The
CO2 source can include HCO
−
3 , which is readily available in
the rumen (Bailey and Oxford, 1958; Barnes et al., 1961). For
dextran production by SB, three different growth requirements
are suggested: (i) biotin and ammonium chloride as sole vitamin
and N-source, respectively, (ii) calcium, pantothenate, adenine,
biotin, thiamine and arginine or glutamic acid, or (iii) xanthine
and additional amino acids (Barnes et al., 1961). Prototroph
SGG in contrast to SB biotype II likely possess the metabolic
capabilities to produce biofilm even in niches not meeting these
growth requirements (Rusniok et al., 2010).
Dextran production furthermore seems to play a role in
ruminal acidosis (Humer et al., 2018). It is hypothesized that the
higher sucrose content of grain feed boosts dextran production in
ruminants to form a slime in the rumen (Cheng et al., 1976; Kulp
and Ponte, 2000; Humer et al., 2018). This slime, comprised of
proteins and polysaccharides of other bacteria, increases viscosity
and produces a froth foam eventually leading to bloat (Cheng
et al., 1976). A key role in the slime production process is
attributed to SB via acidification and dextran production via its
rumen-adapted dextran sucrase (Bailey and Oxford, 1958; Min
et al., 2006).
Virulence Factors of SBSEC Members
Related to Adhesion and Colonization
General Aspects of the Cell Surface in Relation to
Adhesion
The bacterial cell surface has important roles in the interaction
with the environment, the host and for pathogenesis (Nobbs
et al., 2009; Isenring et al., 2018). Lipoproteins featuring a
serine-rich motif following a cysteine residue are frequently
present on the surface of SGG UCN34, possibly linked to
specific interactions with polysaccharides from the environment
(Rusniok et al., 2010). Wall-extracted antigens from the cell
surface of SBSEC members bound equally well to epithelial and
endothelial cell lines as whole SBSEC cells, supporting a role
for cell surface factors in adhesion (Ellmerich et al., 2000a).
Among surface proteins, SB surface protein Sbs6, Sbs10, Sbs13,
and Sbs16 as well as the histone-like protein HlpA, autolysin
AtlA and the cell surface protein antigen C PaC are currently
characterized SBSEC virulence factors besides pili. While HlpA
is present in most SBSEC members, Sbs13, Sbs16, AtlA and PaC
are mainly limited to SGG whereas Sbs6 and Sbs10 are also
regularly observed in SE. Among SGG, only blood-derived SGG
usually feature all seven surface proteins in contrast to rumen or
fecal isolates (Table 4 and Supplementary Data 1). This suggests
reduced or different virulence characteristics of the other SBSEC
members in comparison to blood-derived SGG.
Specific studies were performed on enolase and HlpA. Enolase
is a conserved anchorless surface protein involved in cross-
linking of SGG UCN34 and human epithelial cells (Boleij
et al., 2011a). The main interaction partner was identified as
cytokeratin 8. Cytokeratin 8 is constantly expressed by epithelial
cells, but at increased levels by CRC and could therefore play a
role in the association of SGG with CRC (Boleij et al., 2011a).
HlpA is highly prevalent among SBSEC members possibly
involved in adhesion (Table 4) (Boleij et al., 2009a; Lin et al.,
2011b; Papadimitriou et al., 2014). HlpA is an anchorless
bacterial surface protein that binds to lipoteichoic acid at
the Gram-positive cell wall. Lipoteichoic acid was previously
suggested to be involved in adhesion in cooperation with surface
proteins (Von Hunolstein et al., 1993; Styriak et al., 1994).
Binding to colon tumor cells is then further established via
heparan sulfate proteoglycans (Boleij et al., 2009a). However,
heparin (a heparan sulfate proteoglycan) and lipoteichoic acid
compete for the same binding sites in HlpA which cannot
efficiently bind simultaneously to both structures (Boleij et al.,
2009a) supporting earlier observations that heparin treatment
of rumen SB isolates inhibited lactoferrin-binding (Styriak et al.,
1999). ARH-77syn myeloma cells overexpressing syndecan-1
(the predominant heparan sulfate proteoglycan on epithelial
cells) displayed increased adherence of SB, other streptococci
and staphylococci in contrast to ARH77 cells without syndecan-
1 as well as E. faecalis or E. coli and other Gram-negative
bacteria (Henry-Stanley et al., 2005). Therefore, heparan
sulfate proteoglycans might play a significant role in epithelial
interactions for staphylococci and streptococci to modulate
interactions with tumor epithelial cells (Henry-Stanley et al.,
2005; Boleij et al., 2009a).
The Capsule
The capsular polysaccharide of SBSEC members primarily
consists of galactose, rhamnose and uronic acid. It is produced
from glucose or other carbohydrates and in contrast to
exopolysaccharides does not need CO2 for production (Bailey
and Oxford, 1958). Capsule properties are however strain
dependent. Highly virulent strains, in this case only SGG strains,
possessed a significantly thicker capsule whereas truncated
genes in dairy isolate of SII or SGM might inhibit capsule
production (Vanrobaeys et al., 1999; Boleij et al., 2011b;
Papadimitriou et al., 2014). Genome data suggests a high diversity
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of capsular polysaccharides in SGG, SGP and SII varying in length
between 12 and 19 genes with a conserved start followed by
a strain-specific genetic variability. It is thus related to capsule
heterogeneity and varying antigenic properties (Rusniok et al.,
2010; Hinse et al., 2011b; Lin et al., 2011b; Jans et al., 2013; Jin
et al., 2013; Papadimitriou et al., 2014).
The capsule of many streptococci also comprises hyaluronic
acid, which is important for adhesion to host cells, colonization
and phagocytic killing and infection (Hynes, 2004). Capsule
degradation by hyaluronidase was significantly correlated
with decreasing adherence to epithelial and endothelial cells
(Counihan et al., 2015). Conversely, SL is also able to use
host-derived hyaluronic acid to boost adherence and invasion
suggesting a key role for hyaluronic acid in SBSEC pathogenesis
(Counihan et al., 2015).
Pili and Their Role in Adhesion
A key surface structure involved in the interaction of SBSEC
members with their environment and hosts are fimbriae or
pili. Initially, these specific surface structures were described
as fimbriae among highly virulent SGG of pigeon origin
(Vanrobaeys et al., 1999). However, it seems that currently
recognized pili in SBSEC encompass these fimbriae. Fimbriae
were therefore interpreted accordingly for this review.
In general, SGG harbors three pilus loci termed pil1, pil2, and
pil3, each of which is comprised of three genes (Danne et al.,
2011). The main exceptions among SGG seem to be animal-
derived SGG including the type strain and human fecal SGG,
which harbor incomplete pilus loci or significant mutations in
the genes encoding for collagen-binding and adhesion in pil1
and pil2 (Table 4). In other SBSEC members, the three pilus
loci display signs of genome decay through various mutated,
truncated or completely absent loci and genes (Table 4 and
Supplementary Data 1). Most SE, SII and SGM harbor only pil3
as a complete locus with significant sequence identity to SGG.
pil1 and pil2 loci are frequently incomplete due to truncated
or completely absent genes. Similar to animal-derived SGG, the
genes encoding for collagen-binding and adhesion in pil1 and pil2
are regularly mutated in SE and SII, which leaves open questions
regarding their functional properties. SL and SGP do not seem to
possess any structures resembling the pilus loci of SGG (Table 4
and Supplementary Data 1) (Jans et al., 2013; Papadimitriou
et al., 2014). This might explain the absence of pili in low
virulent SGP (Vanrobaeys et al., 1999) and suggests species-
specific pilus organization. However, genome data is limited to
animal commensal strains but not animal pathogens such as SL
from sea otters or SGP from pigeons, which will be required to
determine the pili and virulence factor repertoire in relation to
SBSEC species and host.
The pil1 locus in SGG is among the most investigated
virulence factors of SGG. The three genes of pil1 encode for two
LPXTG-motif proteins and one sortase C. The two LPXTG-motif
proteins [Gallo_2179 (Pil1A) and Gallo_2178 (Pil1B)] represent
the typical features of pilin subunits with a pilin motif PK
centralized in the protein containing a structural CnaB domain.
Only Pil1A harbors a putative collagen-binding domain (Danne
et al., 2011). The core pilus itself is comprised of heteropolymers
of the two LPXTG-motif proteins while other parts were only
comprised of Pil1A or Pil1B (Danne et al., 2011). A comparative
blast search using the pil1-3 locus proteins of SGG UCN34 to
60 available SBSEC genomes revealed that the collagen-binding
protein Pil1A is unique among human blood SGG (Table 4
and Supplementary Data 1). This suggests that Pil1A is a key
feature of SGG capable of causing IE that might have been lost
or modified in other SGG lineages and SBSEC members. This
highlights further that only some virulence factors specific for
SGG have been unraveled whereas those specific for other SBSEC
members remain mostly unknown.
Each pilus loci and the individual proteins seem to have
specific roles of which only that of pil1 and pil3 have been
elucidated. The role of the pil1 pilus was confirmed to be a
collagen-binding adhesin, important for biofilm formation and
virulence, particularly in IE rat models using SGG UCN34
as model strain (Sillanpää et al., 2009; Danne et al., 2011).
Adhesion assays confirmed preferred collagen I adhesion of pil1
over collagen IV, fibronectin and fibrinogen. This finding is
relevant for the establishment of biofilms by SGG on collagen-
rich surfaces, which are observed in CRC tissues and on damaged
heart valves where it may lead to IE development (Danne et al.,
2011). pil3 is a key factor in binding to mucus, which covers
the intestinal epithelium (Lichtenberger, 1995). In vivo assays
using SGG UCN34 displayed impaired colonization of 1pil3
mutants in the distal colon of mice (Martins et al., 2015). pil3
also binds to human stomach mucins and human fibrinogen.
This supports the importance of pil3 in host adhesion by SGG
UCN34 (Martins et al., 2016) and likely other SGG, SII and SL
harboring pil3 (Table 4), the presence of which correlated directly
with fibrinogen and mucin adhesion in vitro (Jans et al., 2016;
Isenring et al., 2018). This would give pil1 and pil3-carrying
SGG an advantage for the adhesion to CRC tissue featuring
mislocalized MUC5AC mucin and exposed collagen type IV,
the adhesion to fibrinogen at injured sites in the blood system
as well as the colonization of collagen type I exposing surfaces
such as damaged heart valves (Martins et al., 2016). This would
subsequently initiate the first stage of IE.
INVASION AND INFECTION
ESTABLISHMENT
SBSEC as pathobionts are opportunistic invasive pathogens
able to colonize secondary sites via the bloodstream. SBSEC
possess different mechanisms to establish disease by bacterial
translocation, survival in the blood stream and adhesion to
endothelial cell surfaces. In the case of underlying conditions
such as damaged heart valves or CRC, SBSEC possess a selective
advantage and cause severe bacteremia or IE in humans and
animals.
Epithelial Cell Response to Host-Microbe
Interaction
The intestinal epithelial barrier is an important line of defense of
the GIT, as it is proposed to be the main point of entry to cause
infection. Several studies have looked at the ability of SBSEC to
be recognized by the epithelium and result in a local immune
activation and chemoattraction. For example, SGG NCTC8133
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and SGP ATCC 43144 have been shown to induce IL-8 secretion
in buccal epithelial and endothelial cells in a dose-dependent
manner, but not in intestinal Caco-2 cells. While SGG was more
effective in the induction of IL-8 from buccal epithelial cells, SGP
released higher levels of IL-8 from endothelial cells. Furthermore,
SE and SGM induce IL-8 also at mRNA level, while SGG was not
able to induce an IL-8 response in HT-29 and Caco-2 cells. None
of the strains induced IL1-β at mRNA level in intestinal epithelial
colon cells (Boleij et al., 2011b).
In contrast, wall-extracted antigens from SE are very effective
in inducing IL-8 from buccal epithelial cells, endothelial cells
and intestinal epithelial cells (Caco-2). Heat inactivation ablated
the effect of wall-extracted antigens on IL-8 secretion, suggesting
that proteinaceous components of the cell wall are involved in
the IL-8 response (Ellmerich et al., 2000a). Especially the S300
fraction of the wall-extracted antigens was capable of inducing
IL-8 and prostaglandin secretion in Caco-2 cells. Proteins in
the wall-extracted antigens that could be responsible for these
effects were GroEL, SOD, Dpr, Aldolase, Enolase and L-lactate
dehydrogenase (Biarc et al., 2004). In contrast, colonization of
pre-sensitized Balb/C mice with the SB HC5 strain producing
the lantibiotic bovicin HC5, resulted in an increase influx of
eosinofils and reduction of brushborder and goblet cells in the
small intestine, with a 4-fold increase in cell proliferation, while
the large intestine was not affected by this HC5 strain (Paiva et al.,
2012).
Epithelial/Endothelial Translocation and
Invasion
For bacterial invasion, either epithelial invasion or translocation
is necessary to enter the human body. While adherence to
epithelial cells ranged from 2 to 10% for SGG, 2 to 50% for
SE, and 25 to 30% for SGM depending on the cell line used,
internalization was below 0.1% for all strains (Boleij et al., 2011b;
Sánchez-Díaz et al., 2016). SGG strains rarely showed significant
invasion into epithelial cells (Table 5) (Sánchez-Díaz et al., 2016).
The adhesion of SL to Caco-2 cells varied between 0.05 and
0.3%, and only one of 21 SL strains had a high invasion of
0.2% while all others were below 0.1% invasion in Caco-2 cells
(Table 5) (Counihan et al., 2015). However, SGG, but not SGM
and SE, was able to translocate across differentiated epithelial
monolayers (Boleij et al., 2011b), suggesting species and strain-
dependent abilities to invade and translocate epithelial cells as
well as invade endothelial cells (Vollmer et al., 2010). Similarly,
several SL isolates were able to invade HUVEC endothelial cells.
In general, encapsulated strains were found to be more invasive,
which further correlated with the presence of a hyaluronic acid
capsule (Counihan et al., 2015). Some SL strains even have a
mucoid appearance, which in other streptococci is associated
with greater degrees of tissue necrosis and bacteremia (Counihan
et al., 2015).
Survival in Blood and Macrophages and
Activation of the Human Contact System
Survival in blood, activation of the human contact system
and escape from the immune system are pivotal for infection
establishment. For survival in blood, hemolysis can be a beneficial
ability for bacteria to gain access to iron (Malachowa and
DeLeo, 2011). Genome analysis of SBSEC members suggests
the presence of multiple virulence factors related to hemolysis
including hemolytic toxin CylZ as well as hemolysins TLY, III
and A family protein (Jin et al., 2013; Papadimitriou et al.,
2014). In vitro experiments on survival in blood however featured
controversial data likely linked to SBSEC-species dependency.
While serum isolated from heparin-treated blood had little
bactericidal effect on most SBSEC strains, filament-forming SB
strains had a much higher sensitivity to serum (Lorian and
Atkinson, 1978). In contrast to heparin-treated blood, SGG
and some SII demonstrate high survival and growth in citrate-
treated blood similar to Streptococcus pyogenes AP1. Pil1 and
Pil3 mutants seemed to have little effect on survival in blood
whereas a capsule deficient mutant (1cpsD) showed reduced but
not significant lower survival (Isenring et al., 2018).
SGG, but not SII, is able to activate the human contact
system at the bacterial surface. The human contact system is
comprised of a cascade of factors including serine proteases factor
XI, XII and plasma prekallikrein. The co-factor high molecular
weight kininogen and later plasma kallikrein are involved in
degrading kininogen to liberate pro-inflammatory bradykinin
(Isenring et al., 2018). This ability is linked to the presence of the
pil1 locus in the bacteria and the bacteria cell capsule encoded
by multiple genes, one of which being cpsD. Pil1, particularly
the Pil1A protein of this pilus, is able to bind factor XII and
alter the host blood coagulation cascade. Mutants deprived
of pil1 or pil3 showed decreased activity on factor XII and
plasma kallikrein. An inverse correlation was observed for cpsD.
SGG capsule mutant 1cpsD showed increased activity on factor
XII, plasma kallikrein and activated partial thromboplastin-time
prolongation suggesting enhanced interaction between Pil1 and
these factors if not hindered by the capsule. The interference
with the human contact system and coagulation cascade by SGG
suggests that Pil1 is an important factor for the establishment of
IE in humans (Isenring et al., 2018).
Intracellular survival in macrophages and multiplication
are important additional virulence mechanisms of multiple
pathogens. SGG was able to survive in macrophages for up to
24 h and SL was shown to survive up to 48 h in macrophages
(Counihan et al., 2015) whereas most Lactobacillus, Lactococcus
and Bacillus subtilis are efficiently killed within this time-frame
(Boleij et al., 2011b; Counihan et al., 2015). The presence of pil1
and cpsD seems to affect macrophage survival. Non-piliated SGG
mutants had high survival rates to phagocytosis whereas pil1
overexpressing mutants and the1cpsDmutant were killed more
efficiently (Isenring et al., 2018). This supports the protective
effect of the capsule against phagocytosis and the impact of
pilus expression and degree of piliation on immune system
interactions (Danne et al., 2014; Martins et al., 2016). The
addition of purified Pil1 antibodies increased the uptake of pil1
overexpressing but not of1pil1 bacteria by THP-1 macrophages.
The opsonized SGGwere mainly the pil1 high expressing bacteria
and not the weakly piliated cells. This suggests phase variation of
pil1 an important immune evasionmechanism to reach the blood
system (Danne et al., 2014; Martins et al., 2015, 2016). Phase
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TABLE 5 | Invasion and translocation ability of SBSEC species in different cell lines.
SBSEC species with invasion or translocation
% (no. of strains invasion or translocation
positive/total no. of strains)
Cell line SGG SGM SL Isolation
sources
Comments References
Invasion
CRC CELL LINES
Human Caco-2 0% (0/3) – – Human blood SGG UCN34, 1293, NTB1 Boleij et al., 2011b
0% (0/1) – – Human feces SGG NCTC8133 Boleij et al., 2011b
– 0% (0/1) – Dairy SGM CIP105865T Boleij et al., 2011b
– – 82% (14/17) Sea otter IE Only 1 strain with 0.2% invasion, all
others low invasion
Counihan et al., 2015
– – 100% (1/1) Sea otter feces Low invasion Counihan et al., 2015
– – 100% (1/1) Sea otter brain Low invasion Counihan et al., 2015
– – 100% (1/1) Sea otter lymph Low invasion Counihan et al., 2015
– – 100% (1/1) Sea otter ulcer Low invasion Counihan et al., 2015
0% (0/2) – – Bovine feces Low invasion Sánchez-Díaz et al.,
2016
0% (0/2) – – Human blood Low invasion Sánchez-Díaz et al.,
2016
Human HCT116 0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
Human HT-29 0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
Human SW1116 0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
Human SW480 0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
ENDOTHELIAL CELL LINES
Human 494 umbilical
vein HUVEC
– – 76% (13/17) Sea otter IE Low invasion Counihan et al., 2015
[-3.5mm] – – 100% (1/1) Sea otter feces Low invasion Counihan et al., 2015
– – 0% (0/1) Sea otter brain Low invasion Counihan et al., 2015
– – 100% (1/1) Sea otter lymph Low invasion Counihan et al., 2015
– – 100% (1/1) Sea otter ulcer Low invasion Counihan et al., 2015
100% (5/5) – – Human clinical
IE/blood/other
Vollmer et al., 2010
0% (0/1) – – Koala feces SGG DSM16831T Vollmer et al., 2010
Human vascular
endothelial EA.hy926
100%
(21/21)
– – Human clinical
IE/blood/other
Vollmer et al., 2010
0% (0/1) – – Koala feces SGG DSM16831T Vollmer et al., 2010
100% (1/1) – – Shea cake
digester
SGG DSM13808 Vollmer et al., 2010
OTHER CELL LINES
Human lung carcinoma
A549
0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
Human normal colon
epithelial cell line CCD
841 CoN
0% (0/2) – – Human IE SGG TX20005, TX20030, considered
as low to non-invasive
Kumar et al., 2017
Translocation
CRC CELL LINE
Human Caco-2
epithelial monolayer
50% (1/2) – – Bovine feces Sánchez-Díaz et al.,
2016
100% (2/2) – – Human blood Sánchez-Díaz et al.,
2016
100% (3/3) – – Human blood SGG UCN34, 1293, NTB1 Boleij et al., 2011b
100% (1/1) – – Human feces SGG NCTC8133 Boleij et al., 2011b
– 0% (0/1) – Dairy SGM CIP105865T Boleij et al., 2011b
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variation of pil1 has important practical implications regarding
silent infections. Patients can be asymptomatically affected by
SBSEC bacteremia including the potential risk for undetected
underlying CRC or adenomas (Haimowitz et al., 2005; Lin et al.,
2011a; Lee et al., 2013). Pili are however not the only factor
involved in immune system interaction. The rapid killing and
cytokine induction of a non-piliated low virulent SGG strain
lacking pil1 and pil3 (DSM16831T isolated from koala feces) in
contrast to the survival of SGGUCN341pil1 suggests that further
factors besides pil1 are involved in immune system interactions
and the establishment of infection (Grimm et al., 2017b).
Pigeon and duckling infection models allow correlating the
in vitro and in vivo findings. In the pigeon infection models,
the highly virulent SGG strain STR357 was found intracellularly
in 2–20% of macrophages counted in the spleen 96 h post-
infection. SGG seemed to be actively multiplying. However, the
exact mechanism of SGG to avoid killing by macrophages is not
yet clear. Observations of free SGG outside phagosomes suggest
a phagosome escape mechanism rather than the inhibition of
phagosome-lysosome fusion (De Herdt et al., 1995).
In a duckling infection model, SGP resulted in meningitis and
neurological symptoms 3 days post-infection. Macrophages were
hypertrophic with abundant replicating SGP within phagosomes
of degeneratingmacrophages causing necroptosis (Li et al., 2013).
Based on these data SGG, SGP, and SL are capable of surviving in
the blood stream, resisting phagocytosis and evading the immune
system with strong dependency on the extracellular capsule, pili
phase variation and so far unknown virulence factors.
Causation of Infective Endocarditis
Native-valve IE is caused by the colonization of damaged
endothelial tissue of heart valves by bacteria such as
Staphylococcus aureus, enterococci or SBSEC members (Hoen
and Duval, 2013). SBSEC members are suspected to cause
significant endocardial endothelial damage (Schoemaker et al.,
1994). The minimal infectious dose to reach a lethal dose (LD90)
in an experimental rat IE model was determined to be 104 CFU
and is comparable to the LD90 of other IE pathogens (Danne
et al., 2011). Important factors for the establishment of IE are
binding of the bacteria to the endocardium and formation of a
biofilm to shield microbes from immune attacks. The injured
heart valve is recruited by platelets and fibrin, but also collagen
was shown to be present in sterile injured valves. These sterile
plaques (nonbacterial thrombotic endocarditis) can be colonized
by pathogens during bacteremia. SB have a high adherence
capability to normal valves, but an even 5-times increased
binding to damaged aortic valves. Pil1 and Pil3 likely mediate
this binding. Pil1, a collagen-binding adhesin, was shown to be
important for IE establishment in a rat IE model and required
for the initial establishment of an endocardial vegetation (Danne
et al., 2011). Pil3 is of importance due to its ability to bind
to fibrinogen. Due to platelet recruitment to injured sites,
pil3-expressing strains have significantly improved ability to
colonize the injured endocardium (Martins et al., 2016). Glucan-
producing abilities of strains might further enhance binding
to the endocardium. Treatment with dextranase inhibited the
binding of glucan-positive strains, but not of glucan-negative
strains, showing that the capsular glucan presence can be of
significant importance for the binding efficiency of SB to injured
sites (Ramirez-Ronda, 1978).
Further propagation of IE is linked again to the human contact
system involving the coagulation cascade and the potent pro-
inflammatory peptide bradykinin (Isenring et al., 2018). SGG
UCN34 seems to prolong the intrinsic coagulation time by
binding and activating factors of the human contact system
on its surface. These findings were strongly related to Pil1.
SII usually only possesses Pil3 explaining its inability to bind
factor XII or plasma kallikrein, possibly reducing the overall
impact of SII vs. SGG on coagulation time prolongation in the
blood system. Likely, only wildtype SGG possess the capability
to fully degrade kininogen in contrast to mutants with deletion
of pili (1pil1 or 1pil3) or capsule (1cpsD) and overexpression
of pil1 (1term). Since kininogen degradation leads to the
release of bradykinin, also bradykinin release was significantly
reduced in all mutant strains although not completely inhibited
(Isenring et al., 2018). This supports the major role of Pil1 in
the pathogenesis of SGG. Pathogenesis is likely also influenced
by other factors including Pil3, glucan producing abilities and
the capsule. Additional factors and their roles in pathogenesis
in SGG and other SBSEC members, particularly that of Pil2,
are still unknown. Based on current knowledge, this resulted
in the postulation of the following IE model for SGG: SGG
upon entering into the bloodstream can survive and multiply.
Subsequently, the coagulation cascade is activated leading to a
procoagulant state. The bacteria can then adhere to exposed
collagen, most likely type I, on heart valves via Pil1-binding.
This further activates contact factors at the bacterial surface
and via the contact system cascade, leads to a release of
bradykinin that binds to its receptor to trigger IE (Isenring et al.,
2018).
CLINICAL INFECTIONS AND
HOST-IMMUNE RESPONSE DUE TO
SBSEC IN ANIMALS AND HUMANS
Causation of IE and Bacteremia
SBSECmembers are placed among the top-five causes for human
IE globally and responsible for up to 6% of confirmed IE cases
(Hoen et al., 2005; Vogkou et al., 2016). SBSEC as causal agents
of IE increased from 10% to over 20% of all streptococcal IE cases
in Europe and the USA with a particular hotspot in France (Hoen
et al., 2005). Of the SBSEC bacteremia cases, 47% developed into
IE (Barnham and Weightman, 2004). SBSEC IE is particularly
common in patients with congenital heart defects, prosthetic
valves, heart-care associated cross infections, diabetes, living in
rural areas and also increasingly affects healthy valves of subjects
>65 years (Barrau et al., 2004; Corredoira et al., 2008; Vogkou
et al., 2016).
SGG seems to be the main causative agent of IE in humans
in comparison with SGP, SII and SL. Between seven to over 50%
of cases are attributed to SGG followed by 17–30% to SGP and
roughly 30% to SL with strong regional differences (Beck et al.,
2008; Boleij et al., 2011c; Romero et al., 2011; Lazarovitch et al.,
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2013; Sheng et al., 2014; Marmolin et al., 2016; Ben-Chetrit et al.,
2017).
SBSEC members are also of high importance for bacteremia
and IE in animals (Jans et al., 2015). In pigeons, SGG and SGP
were found as the etiological agent for bacteremia and IE causing
spontaneous infections that result in liver-, kidney- and spleen-
swelling (Devriese et al., 1990, 1998). The preferred route of
infection is suggested to be the GIT (Kimpe et al., 2003). SL has
been associated with bacteremia and IE in sea otters (Counihan-
Edgar et al., 2012; Counihan et al., 2015) and is often isolated
from the GIT, cardiac valve lesions, heart, blood, brain, and other
organs of sea otters that died due to IE, but hardly ever from
the GIT of healthy sea otters. Still, the GIT is suggested as the
preferred route of entry for SL (Counihan et al., 2015). The
disease shows high similarity with IE in humans, which suggests
similar patterns in infection establishment, and thus the need for
common concepts that help to identify SBSEC-specific virulence
factors.
Association of IE With Underlying CRC and
Hepatobiliary Disorders
SBSEC bacteremia and IE have a much stronger association with
colon neoplasia than tumor colonization of SBSEC. A meta-
analysis clearly indicated that especially SGG IE has a very high
association with neoplasia (OR 7.26, CI 3.94–13.36) compared
to SB biotype II species. The median prevalence of neoplasia
in SB infected patients was 60%, and was higher for adenomas
(43%) than for carcinomas (18%). SB infection could therefore
be predominantly associated with premalignant colonic lesions,
which underscores the importance of colon examination for
colon pathologies (Boleij et al., 2009b, 2011c). This is supported
by the fact that most neoplasias are identified during the
episode of bacteremia in surveillance studies. Surveillance of
SGG bacteremia patients resulted in 57 new neoplasias (seven
carcinomas and 23 advanced adenomas) in 232 patients (24.6%)
with a mean follow-up of 41.8 months. In Clostridium septicum
bacteremia patients, no new neoplasias were found with a mean
follow-up of 37.4 months (Corredoira et al., 2017). Retrospective
analysis of patients with a previous SB bacteremia revealed the
detection of three CRCs and seven adenomas in 14 patient that
underwent colonoscopy (72% detection rate) (McKenna et al.,
2011) strongly supporting the association of SBSEC IE with gut
pathologies. This might support the theory that SGG bacteremia
frequently has an intestinal source and is a marker for intestinal
SGG colonization.
Stratified by SBSEC species (Table 6), SGG associates with
colon pathology in 28.6–70.7% of cases varying from 16.1 to
52.5% for adenomas and 3.6–33.3% for carcinomas (Tripodi
et al., 2004; Beck et al., 2008; Romero et al., 2011; Corredoira
et al., 2013b, 2017; Lazarovitch et al., 2013; Sheng et al., 2014;
Ben-Chetrit et al., 2017), SGP associates with 0.0–45.8% colon
pathologies in 200 cases of which 126 were reported from Asia
(Beck et al., 2008; Romero et al., 2011; Lazarovitch et al., 2013;
Sheng et al., 2014; Ben-Chetrit et al., 2017). For SL, the data
is more controversial ranging from 0.0 to 50.0% for colon
pathologies, 21.4 and 33.3% reported by 2 studies for adenomas
and only 1 study reported a rate of 7.1% for carcinomas. Similarly,
data for SII and SGM are very limited showing an overall
neoplasia rate of 14.3% for SII and 100% for SGM, often relying
on a few single cases (Table 6) (Beck et al., 2008; Romero et al.,
2011; Lazarovitch et al., 2013; Sheng et al., 2014; Ben-Chetrit
et al., 2017). Meta-analysis of these studies together revealed
colon pathology for SBSEC in 40.7% (n = 786) and divided by
subspecies for SGG in 51.7% (n = 462), SGP in 24.5% (n = 200)
and SL in 24.2% (n = 33) (Ben-Chetrit et al., 2017). However,
in all these studies there was no control group reflecting the
prevalence of colorectal adenomas in the general population>65
years of age that is estimated to be between 10 and 25% (Boleij
et al., 2011c).
Interestingly, it is suggested that SII has a different association
with neoplasia than SGG. SGG is more often associated with
smaller asymptomatic non-advanced and advanced adenomas,
while SII is generally an uncommon observation but more
likely associated with larger tumors at a more advanced stage
(Corredoira et al., 2013a; Stein, 2013). Based on this meta-
analysis, this seems not the case as no carcinomas were found
in any of the SII cases and adenomas and carcinomas were found
almost equally in SGP (11.0 vs. 11.5%, respectively), although the
association of SGGwith adenomas was confirmed in five of seven
studies (39.4 vs. 11.7% in carcinomas; Table 6) (Tripodi et al.,
2004; Beck et al., 2008; Romero et al., 2011; Corredoira et al.,
2013b, 2017).
Besides the obvious association with neoplasia, hepatobiliary
disorders such as chronic liver diseases and liver cirrhosis seem to
be highly prevalent among SBSEC IE patients (Gonzlez-Quintela
et al., 2001; Tripodi et al., 2004). About 20% of all SB bacteremia
cases have an association with underlying biliary origin of
which 59% was isolated from polymicrobial infections, most
frequently in combination with Escherichia coli and Enterococcus
spp (Corredoira et al., 2014).The specific species associations
with hepatobiliary disorders vary for SGP (10–83%) and SL (25–
60%) followed by SGG (2–35%) and rarely for SII, SGM and
S. alactolyticus (Beck et al., 2008; Romero et al., 2011; Lazarovitch
et al., 2013; Corredoira et al., 2014; Sheng et al., 2014; Toepfner
et al., 2014; Almeida et al., 2016). In rare cases, SB was obtained
from cerebrospinal fluid and blood culture of patients with liver
cirrhosis that developed bacterial meningitis (Barahona-Garrido
et al., 2010). Urinary tract infections are a further infection caused
by SBSEC members, particularly SGP, which are responsible for
nearly 10% of cases in Vietnam (Poulsen et al., 2012).
Immunogenic Molecules and Antibody
Response
Lessons From Animal Vaccination
SBSEC colonization and infection leads to immune responses by
the host recognizing immunogenic molecules on SBSEC. Some
of these immunogenic molecules have been discovered by the
development of vaccines for SB in cattle. Parental immunization
with SB using three boosters reduced clinical signs of lactic
acidosis in cattle and has been a partly effective strategy. Feed
intake in immunized sheep and steers was higher, there was
a lower prevalence of diarrhea and they all survived grain
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challenge that results in the drop of rumen pH (Shu et al.,
1999, 2000a; Gill et al., 2000). This immunization strategy
resulted in a long-lasting serum and saliva anti-SB IgG response
in steers and sheep. Although effective antibody levels were
generated, it did not result in complete removal of SB from
the rumen (Gill et al., 2000; Shu et al., 2000a,b, 2001). Feeding
trials in mice using mozzarella cheese prepared from SGM or
SGM in combinations with S. thermophilus and Lactobacillus
bulgaricus as well as only S. thermophilus and Lb. bulgaricus also
increased IL1-β levels for all combinations. However, only cheese
preparedwith SGM increased TNF-α and IL6 suggesting immune
stimulation by SGM without inducing significant differences
in mice body weight gain, spleen index and thymus index
(Cho et al., 2012).
The bacteria cell surface likely plays a crucial role in SBSEC
antigenicity. SB of CRC patients harbor an immunogenic
surface molecule comparable to human choriogonadotropin.
Vaccines prepared with chemically killed SB containing this
human choriogonadotropin-like material on the cell surface
have immunogenic properties and elicited antibody responses
in rabbits. These antibodies also reacted with the human
trophoblastic hormone and were similar to antibodies produced
by human choriogonadotropin (Domingue et al., 1986; Acevedo
et al., 1987). Furthermore, capsule and cell wall may contribute
to the antigenicity of SB. This was observed via a lower cross-
reactivity index for encapsulated strains (range 9.4–12.4%) than
non-encapsulated strains (range 28.9–56.1%). This suggested
antigenicity of capsule components and therefore a potential
contribution of capsule and cell wall to the antigenicity of SB. In
fact, colonization and antibody response of pigeons immunized
with an SGP strain containing a thin irregular capsule (PDH 827)
did not protect against a high-virulent strain SGG strain with a
thick capsule (STR357). These findings indicate that supernatant
proteins, glycans, fimbriae and the capsule may be involved in
the induction of protective immunity against SGG infections
but likely not across SBSEC species (Kane and Karakawa, 1969;
Kane et al., 1972; Pazur and Forsberg, 1978; Pazur et al., 1978;
Vanrobaeys et al., 1997; Kimpe et al., 2002).
Humoral Reactions in IE
During establishment of IE, the immune system tries to clear
the infection with SB. In several studies, the specific humoral
response to SB has been investigated by crossing isolated
pathogens or sterilized antigen compounds with the patients
serum. By using SGG NCTC8133, 11 antigens between 41 and
130 kDa were detected via immunoblotting of two IE patient sera.
Both IE patients produced strong IgG responses to many bands
with a limited cross-reaction to enterococci (Burnie et al., 1987),
but also considerable variation was found between SE and SB
biotype II (SII, SL, or SGP) (Darjee and Gibb, 1993). The presence
of antibody responses to common (c) antigen was specific to
the SB isolates, but not to other Gram-positive IE isolates. This
antigen did not lose its antigenicity by trypsin treatment or
boiling, but changes in the pH from 7 to 5 had a significant
reversible impact on antigenicity (Kaplan et al., 1983). In pigeons,
a similar approach identified a 114-kDa immunogenic protein
that was only recognized on highly virulent SGGs and two
proteins (115 and 207 kDa) that were only recognized on low
virulent SGG strains (Vanrobaeys et al., 2000b). Furthermore,
antibodies to SGG are also common in the low molecular weight
proteome. In the wall-extracted antigens, HlpA and RPL7/L12
have been identified as potential immunogenic proteins. These
anchorless surface proteins might have important functions for
host-microbe interactions as observed for the surface-exposed
enolase from Streptococcus pneumoniae in tissue invasion
(Tjalsma et al., 2007).
SBSEC Humoral Response for Detection of CRC
Because of the specific antibody response to SBSEC and the
strong correlation with colorectal adenomas and carcinomas,
several studies have tried to identify adenoma and CRC patients
utilizing the specific antibody response to SBSEC in general or
to specific SBSEC surface proteins. The IgG antibody responses
to whole cell extracted protein preparations from SE and SB
were higher in patients with CRC than controls, but not for
IgM titers (Darjee and Gibb, 1993). A similar approach with
immunoblot of whole antigen extracts showed specific proteins
at 22 kDa band that was associated with neoplasia (OR 7.98; 95%
CI: 3.54–17.93) and in combination with a 30-kDa band resulted
in an OR of 22.37 (CI 3.77–131.64) with a very high specificity
(84.9% 22 kDa and 98.1% 30 kDa) and lower sensitivity (58.6%
22kDa and 30.1% 30 kDa) (Garza-González et al., 2012). These
data were confirmed for wall-extracted antigen extracts from
SGG showing increased seroprevalence in CRC and adenoma
patients compared to colonoscopy controls (Abdulamir et al.,
2009).
Specific approaches to antigenic proteins revealed that HlpA
and RpL7/L12 wall-extracted antigen proteins from SGG were
diagnostic for CRC (Tjalsma et al., 2006; Tjalsma, 2010). A
detailed analysis revealed a positive correlation of anti-RpL7/L12
levels with age and the presence of colon polyps. Both adenoma
and stage I/II CRC patients contained the highest anti-RpL7/L12
titers, which were significantly different from those of healthy
individuals and advanced stage CRC patients, suggesting a
temporal relation with early stage colonic lesions. A drawback of
RpL7/L12 is the conserved nature within the bacterial kingdom
and significant cross-reactivity resulting in significant overlap
in serum from healthy controls and CRC patients (Boleij et al.,
2010).
The IgG response to four SGG pili proteins (Pil1A, Pil1B,
Pil2B, and Pil3B) was tested in single plex and multiplex assays.
The IgG response to Pil1B was the best predictor for tumor
presence, but did not result in the same response in all IE
infected patients. CRC patients generally had response to only
one of the four antigens with a maximum sensitivity of 20–
43% by combination of four antigens (Boleij et al., 2012b).
In the multiplex assay, the strongest association with CRC
seropositivity was found by a combination of Pil1A and B
(OR 3.54; 95% CI 1.49–8.44) and it was more predictive in
patients with an age below 65 years. Although very specific,
only a limited number of CRC cases could be identified using
this approach (Butt et al., 2016). The association with Pil1B
was confirmed in an independent cohort (OR 4.3; CI 2.14–
8.65), but not for Pil1A. Interestingly, a specific association
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with non-advanced adenomas was found using a 6-marker
panel with at least a positive seroresponse to two of six
markers (OR 2.98; 95% CI: 1.18–7.57). With this marker panel,
27% of SGG-positives cases among non-advanced adenomas
were identified compared to 11% of controls. Additionally,
7% of non-advanced adenomas were double-positive to Pil1A-
Pil1B, compared to 0% of controls (p-value < 0.0001) (Butt
et al., 2017). Data from a recent nested case-control study
confirm previous observations that single marker panels are
not sufficient to identify CRC patients and adenomas (Butt
et al., 2017, 2018). This is potentially due to significant
heterogeneity in IgG response between patients and depends on
the antigenicity of the strain triggering the immune response.
Nevertheless, these three studies confirm the strong and
specific association of SGG with CRC and adenomas of the
colon.
INTERPRETATION AND CONCLUSION
SBSEC pathobionts inhabit the GIT of animals and humans
as well as food products featuring significant niche adaptation.
While SGG retained most genetic and functional properties
for a large variety of niches, SGP, SL, SII and particularly
SGM have adapted more specifically to certain niches by
gene gain and loss. SBSEC colonization as part of the
rumen and gut microbiota is not ubiquitous and confers
only a small sub-population of the overall microbiota
during symbiosis. However, their ability to proliferate and
colonize in dysbiosis, e.g., ruminal acidosis or in the tumor
microenvironment is significantly enhanced and defines their
pathogenicity.
Although SBSEC are not often found in association with
tumors in microbiome studies, they likely have increased
colonization levels at tumor sites. A potential tumor promoting
ability of SGG may shape their microenvironment further
and support the association with neoplastic sites. Increased
immune responses in CRC patients toward SGG suggests a
strong association with these sites. Considering the bacterial
driver-passenger model, it seems that particularly SGG could
be considered as a neoplastic site hijacker. SGG only excels
when colonization factors and growth conditions in the
environment are favorable. SGG is then able to further shape the
microenvironment to its benefit.
This could also explain controversies between the relation
of SBSEC with CRC in IE matched and unmatched patients.
As SBSEC members are not strong ubiquitous gut colonizers
and nonobligatory passengers on CRC, their prevalence among
the general CRC population is low in contrast to patients
with SBSEC IE. This also supports the proposed route of
infection in humans and animals alike: SBSEC members, mostly
SGG, are only able to colonize neoplastic tissues selectively.
Subsequently, some strains have the capacity to translocate
across the epithelial barrier into the blood system. Human
blood-derived SGG possess the full pil1, pil2, and pil3 loci,
which enable adhesion to endothelial cells, exposed collagen
and fibrinogen on heart valves and activate the human contact
system. Via pili phase variation and expression of a capsular
polysaccharide they can survive phagocytosis and minimize
activation of the humoral immune response. SGG strains of
animal origin and other SBSEC members without full pilus
loci or different pilus proteins likely do not possess the same
degree of infection ability and might depend on other factors to
establish infection. Thus, animal and food-derived strains often
adhere best to collagen type IV, whereas human-derived strains,
particularly those of bacteremia or IE origin, predominantly
show highest adhesion toward collagen type I. However, data is
so far limited to presumed commensal animal strains whereas
animal pathogens are not characterized leaving open question
regarding virulence factors, host specificity but also zoonosis.
In the light of SBSEC zoonotic potential, association with rural
areas and prevalence in food, it will be relevant to determine
the factors that enable colonization and establishment in animal
and human hosts alike and provide comparison to food-derived
strains. This will greatly contribute to a better understanding of
transmission routes and development of intervention strategies
to mitigate health risks associated with individual SBSEC
members.
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